Correlates of time to approval and other clinical development periods.

Volume: 24, Issue: 9, Pages: 1871 - 1876
Published: Sep 1, 2019
Abstract
The drug development cycle is classically divided into a clinical phase and review phase, with the clinical phase typically being further partitioned based on the planning and conduct of adequate and well controlled trials. Factors affecting the duration of the development intervals have not previously been systematically investigated. Here, we analyze a large population (N=825) of New Drug Applications (NDAs) approved between 2008 and 2017 to...
Paper Details
Title
Correlates of time to approval and other clinical development periods.
Published Date
Sep 1, 2019
Volume
24
Issue
9
Pages
1871 - 1876
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.